Rising antimicrobial resistance in STIs: A call for global action

Review delves into the rising challenge of antimicrobial resistance in sexually transmitted infections, underscoring the need for innovative treatments and the critical role of global surveillance in managing diseases like gonorrhea and syphilis.

Lupin signs deal with Takeda to launch Vonoprazan in India

The agreement will allow Lupin to expand its gastroenterology portfolio in the Indian market. Credit: Orawan Pattarawimonchai/Shutterstock. Pharmaceutical company Lupin has announced a non-exclusive patent

September 19, 2024

The national decline in overdose deaths is leaving Black communities behind

For years, we have studied and cared for patients living with a condition that resulted in annual death rates in the U.S. of more than

January 24, 2025

China approves Eli Lilly’s weight loss drug as country launches obesity awareness campaign

Eli Lilly’s tirzepatide has been approved for weight management in China, entering what’s expected to be a substantial market for GLP-1s. Tirzepatide — marketed in

July 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.